Clinical impact of HTLV-1 infection in Spain: Implications for public health and mandatory screening [3]

Journal of Acquired Immune Deficiency Syndromes

Volumn 30, Issue 3, 2002, Pages 366-368

  Toro, Carlos ^a   Rodés, Berta ^a   Aguilera, Antonio ^a   Caballero, Estrella ^a   Benito, Rafael ^a   Tuset, Concepción ^a   García, Juan ^a   De Lejarazu, Raúl Ortiz ^a   Eirós, José M ^a   Calderón, Enrique ^a   Rodriguez, Carmen ^a   Soriano, Vincent ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ADULT; AGED; ANTIBODY SCREENING; CLINICAL FEATURE; COMORBIDITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; LETTER; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; SCREENING TEST; SEROEPIDEMIOLOGY; SPAIN; T CELL LYMPHOMA; VIRUS TRANSMISSION;

EID: 0036639846     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200207010-00016     Document Type: Letter

References (8)

1. Human T-lymphotropic virus type 1 infection
2. Global epidemic of human T-cell lymphotropic virus type-1 (HTLV-1)
3. The epidemiology and clinical impact of HTLV infections in Europe
4. Human T-cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: Population study
5. Prevalence of HTLV infection in pregnant women in Spain
6. E. strongyloides and HTLV-1 infection
7. Lymphomatoid granulomatosis: Clinical and pathological analysis of 7 cases
8. HTLV-I/II infections in Spain